Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, ZFA02 Adjuvant
Asset
Adjuvanted quadrivalent inactivated split-virion influenza vaccine generating immune response against influenza viruses
- Stage
- Phase 1
- Modality
- Vaccine
- Target
- Not known
- 1
- Indication
- 89
- Trials
- 1
- Developer
Indications
1Human influenza
Phase 1, Recruiting, NCT06824519, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials89
- Evidence for its targets1
- Competitors4
- Signals4
Every asset’s record: target, stage, trials and the evidence behind it.